Characteristics and survival of patients with non-Hodgkin's lymphoma with and without acquired immunodeficiency syndrome

Hematological Oncology

Volumn 20, Issue 4, 2002, Pages 177-187

  Diamond, Catherine ^a   Taylor, Thomas H ^a   Anton Culver, Hoda ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

AIDS; HIV; Non Hodgkin's lymphoma; Survival

Indexed keywords

ANTINEOPLASTIC AGENT; ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGE DISTRIBUTION; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; ETHNIC DIFFERENCE; FEMALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; RACE DIFFERENCE; REVIEW; SEX DIFFERENCE; SURVIVAL RATE; TUMOR LOCALIZATION; TUMOR VOLUME; UNITED STATES;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AGE FACTORS; CALIFORNIA; CELL SURVIVAL; FEMALE; HIV SEROPOSITIVITY; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; MULTIVARIATE ANALYSIS; REGISTRIES; REGRESSION ANALYSIS; SEX FACTORS; TIME FACTORS;

EID: 0036940152     PISSN: 02780232     EISSN: None     Source Type: Journal    
DOI: 10.1002/hon.697     Document Type: Review

References (30)

1. Centers for Disease Control and Prevention, A cluster of Kaposi's sarcoma and Pneumocystis carinii pneumonia among homosexual male residents of Los Angeles and Orange Counties, California. MMWR 1982; 31: 305-307.
2. Coté TR, Biggar RJ, Rosenberg PS, et al. AIDS/Cancer Study Group. Non-Hodgkin's lymphoma among people with AIDS: incidence, presentation, and public health burden. Int J Cancer 1997; 73: 645-650.
3. Coté TR, O'Brien TR, Ward JW, Wilson SE, Blattner WA, National AIDS/Cancer Match Study Group. AIDS and cancer registry linkage: measurement and enhancement of registry completeness. Prev Med 1995; 24: 375-377.
4. Coté TR, Manns A, Hardy CR, Yellin FJ, Hartge P, AIDS/Cancer Study Group. Epidemiology of brain lymphoma among people with or without acquired immunodeficiency syndrome. J Natl Cancer Inst 1996; 88: 675-679.
5. Biggar RJ, Rosenberg RJ, Coté T, Multistate AIDS/Cancer Match Study Group. Kaposi's sarcoma and non-Hodgkin's lymphoma following the diagnosis of AIDS, Int J Cancer 1996; 68: 754-758.
6. Biggar RJ, Frisch M, Goedert JJ, AIDS-Cancer Match Registry Study Group. Risk of cancer in children with AIDS. JAMA 2000; 284: 205-209.
7. Goedert JJ, Coté TR, Virgo P, et al, AIDS-Cancer Match Study Group. Spectrum of AIDS-associated malignant disorders. Lancet 1998; 351: 1833-1839.
8. Frisch M, Biggar RJ, Engels EA, Goedert JJ, AIDS-Cancer Match Registry Group. Association of cancer with AIDS-related immunosuppression in adults. JAMA 2001; 285: 1736-1745.
9. World Health Organization. International Classification of Diseases for Oncology. Percy C, Van Holten V (eds). Calum Muir: Geneva, 1990; xxxii-xxxvi.
10. Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M. Report of the Committee on Hodgkin's Disease Classification. Cancer Res 1971; 31: 1860-1861.
11. Kaplan LD, Northfelt DW. Malignancies associated with AIDS. In The Medical Management of AIDS (6th edn), Sande MA, Volberding PA (eds). W. B. Saunders: Philadelphia, 1999; 478.
12. Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1992; 41: RR-17.
13. Pedersen C, Barton SE, Chiesi A, et al. AIDS in Europe Study Group. HIV-related non-Hodgkin's lymphoma among European AIDS patients. Eur J Haematol 1995; 55: 245-250.
14. Tirelli U, Spina M, Vaccher E, et al. FOA, GICAT. Clinical evaluation of 451 patients with HIV-related non-Hodgkin's lymphoma: experience of the Italian Cooperative Group on AIDS and Tumours (GICAT). Leuk Lymph 1995; 20: 91-96.
15. International Non-Hodgkin's Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 1993; 329: 987-994.
16. Straus DJ, Huang J, Testa MA, Levine AM, Kaplan LD, National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group. Prognostic factors in the treatment of human immunodeficiency virus-associated non-Hodgkin's lymphoma: analysis of AIDS Clinical Trial Group protocol 142 - low dose vs. standard dose m-BACOD plus granulocyte-macrophage colony stimulating factor. J Clin Oncol 1998; 16: 3601-3606.
17. Vaccher E, Tirelli U, Spina M, et al. Age and serum lactate dehydrogenase level are independent prognostic factors in human immunodeficiency virus-related non-Hodgkin's lymphoma. J Clin Oncol 1996; 14: 2217-2223.
18. Levine AM, Shibata D, Sullivan-Halley J, et al. Epidemiological and biological study of acquired immunodeficiency syndrome-related lymphoma in the county of Los Angeles: preliminary results. Cancer Res 1992; 52: 5482s-5484s.
19. Ziegler JL, Beckstead JA, Volberding PA, et al. Non-Hodgkin's lymphoma in 90 homosexual men. N Engl J Med 1984; 311: 565-570.
20. Hooper WC, Holman RC, Clarke MJ, Chorba TL. Trends in non-Hodgkin Lymphoma (NHL) and HIV-associated NHL deaths in the United States. Am J Hematol 2001; 66: 159-166.
21. Kaplan LD, Abrams DI, Feigal E, et al. AIDS-associated non-Hodgkin's lymphoma in San Francisco. JAMA 1989; 261: 719-724.
22. Levine AM, Sullivan-Halley J, Pike MC, et al. Human immunodeficiency virus-related survival: prognostic factors predictive of survival. Cancer 1991; 68: 2466-2472.
23. Rossi G, Donisi A, Cesari S, Re A, Cadeo G, Carosi G. The International Prognostic Index can be used as a guide to treatment decisions regarding patients with human immunodeficiency virus-related systemic non-Hodgkin's lymphoma. Cancer 1999; 86: 2391-2397.
24. Gill PS, Levine AM, Krailo M, et al. AIDS-related malignant lymphoma: results of prospective treatment trials. J Clin Oncol 1987; 5: 1322-1328.
25. Gisselbrecht C, Oksenhendler E, Tirelli U, et al. Human immunodeficiency virus-related lymphoma treatment with intensive combination chemotherapy. French-Italian Cooperative Group. Am J Med 1993; 95: 188-196.
26. Hagemeister FB, Khetan R, Allen P, et al. Stage, serum LDH, and performance status predict disease progression and survival in HIV-associated lymphomas. Ann Oncol 1994; 5(Suppl. 2): S41-S46.
27. Sparano JA, Hu X, Wiernik PH, et al. Opportunistic infection and immunologic function in patients with human immunodeficiency virus-associated non-Hodgkin's lymphoma treated with chemotherapy. J Natl Cancer Inst 1997; 89: 301-307.
28. Ledergerber B, Telenti A, Egger M, for the Swiss HIV Cohort Study. Risk of HIV-related lymphoma, Kaposi's sarcoma and non-Hodgkin's lymphoma with potent antiretroviral therapy: prospective cohort study. BMJ 1999; 319: 23-24.
29. Evison J, Jost J, Lederberger B, Jost L, Strasser F, Weber R. HIV-associated non-Hodgkin's lymphoma: highly active antiretroviral therapy improves remission rate of chemotherapy. AIDS 1999; 13: 732-734.
30. Mocroft A, Katlama C, Johnson AM, et al. EuroSIDA Study Group. AIDS across Europe, 1994-1998, the EuroSIDA Study. Lancet 2000; 356: 291-296.